[ CAS No. 886365-56-6 ]

Name: 886365-56-6|5-Fluoro-3-methylpyridin-2-ylamine|98%
Brand: Ambeed
SKU: A155393
Price: 22.0 USD
Availability: InStock
Rating: 96 (27 reviews)

{[proInfo.proName]} ,{[proInfo.pro_purity]}

Cat. No.: {[proInfo.prAm]}

DV 2D 3D

Structure of 886365-56-6 * Storage: {[proInfo.prStorage]}

Cart0 Bulk Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

For Research Only 88K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 886365-56-6 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 886365-56-6 ]

SDS

Alternatived Products of [ 886365-56-6 ]

Product Details of [ 886365-56-6 ]

CAS No. :	886365-56-6	MDL No. :	MFCD07375130
Formula :	C₆H₇FN₂	Boiling Point :	215.4°C at 760 mmHg
Linear Structure Formula :	-	InChI Key :	-
M.W :	126.13 g/mol	Pubchem ID :	45790032
Synonyms :

Safety of [ 886365-56-6 ]

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P261-P280-P305+P351+P338	UN#:	N/A
Hazard Statements:	H302-H315-H319-H332-H335	Packing Group:	N/A
GHS Pictogram:

Application In Synthesis of [ 886365-56-6 ]

Upstream synthesis route of [ 886365-56-6 ]
Downstream synthetic route of [ 886365-56-6 ]

[ 886365-56-6 ] Synthesis Path-Upstream 1~1

1
[ 38186-84-4 ]
[ 886365-56-6 ]

Yield	Reaction Conditions	Operation in experiment
55.2%	Stage #1: With Benzophenone imine; sodium t-butanolate In toluene at 80℃; for 1 h; Stage #2: With hydrogenchloride; water In tetrahydrofuran at 20℃; for 1.5 h; Stage #3: With sodium hydrogencarbonate In tetrahydrofuran; water	To a solution of 2-chloro-5-fluoro-3-methylpyridine D38 (0.50 g, 2.82 mmol) in dry toluene (12.5 ml) were added sodium t-butoxyde (0.462 g, 4.81 mmol), Pd₂(dba)₃(0.315 g, 0.344 mmol), BINAP (0.642 g, 1.031 mmol) and benzophenone imine (0.692 ml, 4.12 mmol). The resulting mixture was degassed (3.x.pump/N₂) and then heated to 80° C. After 1 h stirring, the mixture was cooled down to room temperature, diluted with Et₂O (400 ml) and filtered through a celite pad. Volatiles were evaporated, the resulting oil was dissolved in THF (34 ml) and HCl (1.408 ml of a 2 M aqueous solution, 2.82 mmol) was added. The mixture was stirred at room temperature for 1.5 h, then neutralized with a saturated NaHCO₃aqueous solution and diluted with DCM (200 ml). The inorganic layer was back-extracted with DCM (2.x.50 ml). The collected organic layers were dried (Na₂SO₄), filtered and evaporated. The residue was purified by flash chromatography on silica gel (Biotage SP4 12M, Cy/EtOAc 60/40). Collected fractions gave the title compound D39 (0.20 g, 1.554 mmol, 55.2percent yield from D38, two steps), as an orange solid. MS: (ES/+) m/z: 127 (M+1). C₆H₇FN₂requires 126.¹H NMR (400 MHz, DMSO-d₆) δ(ppm): 7.73 (d, 1H), 7.23 (dd, 1H), 5.60 (bs, 2H), 2.04 (s, 3H).

Reference： [1] Patent: US2009/22670, 2009, A1, . Location in patent: Page/Page column 20
[2] Patent: WO2010/72722, 2010, A1, . Location in patent: Page/Page column 27

[ 886365-56-6 ] Synthesis Path-Downstream 1~26

1
[ 38186-84-4 ]
[ 886365-56-6 ]

Yield	Reaction Conditions	Operation in experiment
55.2%		To a solution of <strong>[38186-84-4]2-chloro-5-fluoro-3-methylpyridine</strong> D38 (0.50 g, 2.82 mmol) in dry toluene (12.5 ml) were added sodium t-butoxyde (0.462 g, 4.81 mmol), Pd2(dba)3 (0.315 g, 0.344 mmol), BINAP (0.642 g, 1.031 mmol) and benzophenone imine (0.692 ml, 4.12 mmol). The resulting mixture was degassed (3.x.pump/N2) and then heated to 80° C. After 1 h stirring, the mixture was cooled down to room temperature, diluted with Et2O (400 ml) and filtered through a celite pad. Volatiles were evaporated, the resulting oil was dissolved in THF (34 ml) and HCl (1.408 ml of a 2 M aqueous solution, 2.82 mmol) was added. The mixture was stirred at room temperature for 1.5 h, then neutralized with a saturated NaHCO3 aqueous solution and diluted with DCM (200 ml). The inorganic layer was back-extracted with DCM (2.x.50 ml). The collected organic layers were dried (Na2SO4), filtered and evaporated. The residue was purified by flash chromatography on silica gel (Biotage SP4 12M, Cy/EtOAc 60/40). Collected fractions gave the title compound D39 (0.20 g, 1.554 mmol, 55.2percent yield from D38, two steps), as an orange solid. MS: (ES/+) m/z: 127 (M+1). C6H7FN2 requires 126.1H NMR (400 MHz, DMSO-d6) delta(ppm): 7.73 (d, 1H), 7.23 (dd, 1H), 5.60 (bs, 2H), 2.04 (s, 3H).
		5-Fluoro-3-methyl-2-pyridinamine (DIl): To a solution of <strong>[38186-84-4]2-chloro-5-fluoro-3-methylpyridine</strong> DlO (0.50 g) in dry toluene (12.5 ml) were added sodium t-butoxyde (0.462 g, 4.81 mmol), Pd2(dba)3 (0.315 g, 0.344 mmol), BINAP (0.642 g, 1.031 mmol) and benzophenone imine (0.692 ml, 4.12 mmol). The resulting mixture was degassed (3 x pump/N2) and then heated to 80 0C. After 1 hour stirring, the mixture was cooled down to room temperature, diluted with Et2O (400 ml) and filtered through a celite pad. Volatiles were evaporated, the resulting oil was dissolved in THF (34 ml) and HCl (1.408 ml of a 2 M aqueous solution, 2.82 mmol) was added. The mixture was stirred at room temperature for 1.5 hours, then neutralized with a saturated NaHCO3 aqueous solution and diluted with DCM (200 ml). The inorganic layer was back- extracted with DCM (2 x 50 ml). The collected organic layers were dried (Na2SO4), filtered and evaporated. The residue was purified by flash chromatography on silica gel (Biotage SP4 12M column, Cy/EtOAc 60/40). Collected fractions gave the title compound DIl (0.20 g) as an orange solid. MS: (ES/+) m/z: 127 (M+l). C6H7FN2 requires 126. 1H NMR (400 MHz, DMSO-J6) delta ppm: 7.73 (d, 1 H), 7.23 (dd, 1 H), 5.60 (bs, 2 H), 2.04 (s, 3 H).

Reference： [1]Patent: US2009/22670,2009,A1 .Location in patent: Page/Page column 20
[2]Patent: WO2010/72722,2010,A1 .Location in patent: Page/Page column 27

2
[ 886365-56-6 ]
[ 1097180-24-9 ]
[ 1097264-83-9 ]
C₁₉H₂₆FN₃O₂ [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	In N,N-dimethyl-formamide; at 80℃; for 1h;	To a solution of 1,1-dimethylethyl (2S)-2-(3-bromo-2-oxopropyl)-1-piperidinecarboxylate D2 (0.15 g, 0.468 mmol) in DMF (1 ml) was added <strong>[886365-56-6]5-fluoro-3-methyl-2-pyridinamine</strong> D39 (0.0709 g, 0.562 mmol) and the mixture was stirred at 80 C. for 1 h. The reaction mixture was eluted through a SCX column. Collected fractions gave 0.137 g of an oil containing a mixture of the title compound, the corresponding N-Boc protected derivative and some residual <strong>[886365-56-6]5-fluoro-3-methyl-2-pyridinamine</strong>. [N-Boc derivative data. UPLC: rt=0.56 min, peak observed: 348 (M+1). C19H26FN3O2 requires 347]. The crude was dissolved in DCM (2 ml) and the resulting solution cooled to 0 C. TFA (0.40 ml) was added dropwise, the reaction left under stirring for 1 h and then eluted through a SCX column. Collected fractions gave the title compound as a free base D40a (0.093 g) contaminated with <strong>[886365-56-6]5-fluoro-3-methyl-2-pyridinamine</strong>. The material was used without further purification in the next step. UPLC: rt=0.35 min, peak observed: 248 (M+1). C14H18FN3 requires 247.
		To a solution of 1,1-dimethylethyl (25)-2-(3-bromo-2-oxopropyl)-l-piperidinecarboxylate D2 (0.15 g) in DMF (1 ml) was added 5-fiuoro-3-methyl-2-pyridinamine Dl 1 (0.0709 g) and the mixture was stirred at 80 0C for 1 hour. The reaction mixture was eluted through a SCX column. Collected fractions gave 0.137 g of an oil containing a mixture of the title compound, the corresponding N-Boc protected derivative and some residual 5-fluoro-3- methyl-2-pyridinamine. [Lambda/-Boc derivative data. UPLC: rt = 0.56 min, peak observed: 348 (M+l). C19H26FN3O2 requires 347]. The crude was dissolved in DCM (2 ml) and the resulting solution cooled to 0 0C. TFA (0.40 ml) was added dropwise, the reaction left under stirring for 1 hour and then eluted through a SCX column. Collected fractions gave the title compound as a free base D12 (0.093 g) contaminated with 5-fluoro-3-methyl-2- pyridinamine. The material was used without further purification in the next step. MS: (ES/+) m/z: 248 (M+l). C14Hi8FN3 requires 247.

Reference： [1]Patent: US2009/22670,2009,A1 .Location in patent: Page/Page column 20
[2]Patent: WO2010/72722,2010,A1 .Location in patent: Page/Page column 27

3
[ 886365-56-6 ]
[ 1097180-24-9 ]
6-fluoro-8-methyl-2-[(2S)-2-piperidinylmethyl]imidazo[1,2-a]pyridine dihydrochloride [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
59%		A mixture of 1,1-dimethylethyl (2S)-2-(3-bromo-2-oxopropyl)-1-piperidinecarboxylate D2 (0.94 g, 2.93 mmol; prepared by the method of D2 preparation (iii)), <strong>[886365-56-6]5-fluoro-3-methyl-2-pyridinamine</strong> D39 (0.41 g, 3.25 mmol) and NaHCO3 (0.37 g, 4.40 mmol) in toluene (4.70 ml) was stirred at 90 C. overnight. The mixture was allowed to cool down to room temperature and the inorganic salts were removed by filtration. The solid cake was washed with toluene (2×0.94 ml).HCl (5-6 N solution in IPA, 2.22 ml, 11.10-13.32 mmol) was added to 5.18 g of the toluene solution (filtrate, 5.46 g) of the free base D40a. The mixture was heated to 70 C. and the resulting slurry stirred at that temperature under nitrogen atmosphere for 1 h. The slurry was aged at 70 C. for 1 h, cooled down to 40 C. over 2 h, allowed to reach room temperature and then stirred at that temperature overnight. The slurry was cooled down to 0 C. and aged at that temperature for 1 h. The solid was collected by filtration, washed with IPA (2×1.9 ml) and dried under vacuo at 40 C. for 4 h to afford the title compound D40b (0.53 g, 1.75 mmol, 59% yield). 1H NMR (600 MHz, DMSO-d6) delta (ppm): 15.18 (bs, 1H), 9.21 (bs, 1H), 9.07 (bs, 1H), 8.99 (s, 1H), 8.14 (s, 1H), 7.83 (bs, 1H), 3.15-3.65 (m, 4H), 2.61 (s, 3H), 1.85 (d, 1H), 1.69-1.79 (m, 2H), 1.48-1.67 (m, 2H), 1.38-1.48 (m, 1H). HPLC (walk-up, 3 min method): rt=1.28 min.
		A mixture of 1,1-dimethylethyl (25)-2-(3-bromo-2-oxopropyl)-l-piperidinecarboxylate D2 (0.94 g prepared by the method of D2 preparation (iii)), <strong>[886365-56-6]5-fluoro-3-methyl-2-pyridinamine</strong> DIl (0.41 g) and NaHCO3 (0.37 g, 4.40 mmol) in toluene (4.70 ml) was stirred at 90 0C overnight. The mixture was allowed to cool down to room temperature and the inorganic salts were removed by filtration. The solid cake was washed with toluene (2 x 0.94 ml). HCl 5-6 N solution in IPA (2.22 ml, 11.10-13.32 mmol) was added to 5.18 g of the toluene solution (filtrate, 5.46 g) of the free base D12. The mixture was heated to 70 0C and the resulting slurry stirred at that temperature under nitrogen atmosphere for 1 hour. The slurry was aged at 70 0C for 1 hour, cooled down to 40 0C over 2 hours, allowed to reach room temperature and then stirred at that temperature overnight. The slurry was cooled down to 0 0C and aged at that temperature for 1 hour. The solid was collected by filtration, washed with IPA (2 x 1.9 ml) and dried under vacuo at 40 0C for 4 hours to afford the title compound D13 (0.53 g). 1H NMR (OOO MHz, DMSO-J6) delta ppm: 15.18 (bs, 1 H), 9.21 (bs, 1 H), 9.07 (bs, 1 H), 8.99 (s, 1 H), 8.14 (s, 1 H), 7.83 (bs, 1 H), 3.15 - 3.65 (m, 4 H), 2.61 (s, 3 H), 1.85 (d, 1 H), 1.69 - 1.79 (m, 2 H), 1.48 - 1.67 (m, 2 H), 1.38 - 1.48 (m, 1 H). HPLC (walk-up, 3 min method): rt = 1.28 min.

Reference： [1]Patent: US2009/22670,2009,A1 .Location in patent: Page/Page column 20-21
[2]Patent: WO2010/72722,2010,A1 .Location in patent: Page/Page column 28

4
[ 3095-95-2 ]
[ 886365-56-6 ]
[ 1251860-64-6 ]

Reference： [1]Tetrahedron Letters,2010,vol. 51,p. 5154 - 5156

5
[ 886365-56-6 ]
[ 1268817-66-8 ]
[ 1268818-53-6 ]

Yield	Reaction Conditions	Operation in experiment
77%		To a solution of 1 , 1 -dimethylethyl (2S ,5 S)-2-formyl-5 -methyl- 1 -piperidinecarboxylate D3 (975 mg, 3.65 mmol) in DCE (20 ml) were added <strong>[886365-56-6]5-fluoro-3-methyl-2-pyridinamine</strong> (552 mg, 4.38 mmol) and AcOH (1.044 ml, 18.23 mmol). The resulting mixture was stirred for 1 hour at room temperature, then was added Sodium triacetoxyborohydride (1273 mg, 6.01 mmol) and stirred for 4 hours at room temperature. DCM and aqueous saturated NaHCO3 were added and the resulting mixture was made basic with NaHCO3 until pH~8. The aqueous phase was extracted with DCM. The organic layers were dried (Na2SO4), filtered and evaporated under reduced pressure to obtain a brown oil which was purified with (biotage SP4 40 M column, Cy/EtOAc from 100/0 to 90/10) to afford the title compound D14 (950 mg, 2.82 mmol, 77 % yield), N2738-22-1. UPLC: rt = 0.80 min, peak observed: 338 (M+l). C18H28FN3O2 requires 337.

Reference： [1]Patent: WO2011/23585,2011,A1 .Location in patent: Page/Page column 25-26

6
[ 886365-56-6 ]
2-chloro-7-fluoro-9-methyl-pyrido[1,2-a]pyrimidin-4-one [ No CAS ]

Reference： [1]Patent: WO2015/173181,2015,A1
[2]Patent: WO2016/184832,2016,A1
[3]Patent: US2019/315773,2019,A1

7
[ 886365-56-6 ]
7-fluoro-9-methyl-2-(2-methylimidazo[1,2-b]pyridazin-6-yl)pyrido [1,2-a]pyrimidin-4-one [ No CAS ]

Reference： [1]Patent: WO2015/173181,2015,A1
[2]Patent: WO2017/81111,2017,A1
[3]Patent: WO2017/80967,2017,A1
[4]Patent: US2019/315773,2019,A1

8
[ 886365-56-6 ]
2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-7-fluoro-9-methyl-pyrido[1,2-a]pyrimidin-4-one [ No CAS ]

Reference： [1]Patent: WO2015/173181,2015,A1
[2]Patent: WO2017/81111,2017,A1
[3]Patent: WO2017/80967,2017,A1

9
[ 886365-56-6 ]
2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-9-methyl-7-[(3S)-3-methylpiperazin-1-yl]pyrido[1,2-a]pyrimidin-4-one [ No CAS ]

Reference： [1]Patent: WO2015/173181,2015,A1
[2]Patent: WO2017/81111,2017,A1
[3]Patent: WO2017/80967,2017,A1

10
[ 886365-56-6 ]
2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-9-methyl-7-[(3R)-3-methylpiperazin-1-yl]pyrido[1,2-a]pyrimidin-4-one [ No CAS ]

Reference： [1]Patent: WO2015/173181,2015,A1
[2]Patent: WO2017/81111,2017,A1
[3]Patent: WO2017/80967,2017,A1

11
[ 886365-56-6 ]
2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-7-((3R,5S)-3,5-dimethylpiperazin-1-yl)-9-methyl-4H-pyrido[1,2-a]pyrimidin-4-one [ No CAS ]

Reference： [1]Patent: WO2015/173181,2015,A1
[2]Patent: WO2017/81111,2017,A1
[3]Patent: WO2017/80967,2017,A1

12
[ 886365-56-6 ]
2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-7-(3,3-dimethylpiperazin-1-yl)-9-methyl-pyrido[1,2-a]pyrimidin-4-one [ No CAS ]

Reference： [1]Patent: WO2015/173181,2015,A1
[2]Patent: WO2017/81111,2017,A1
[3]Patent: WO2017/80967,2017,A1

13
[ 886365-56-6 ]
2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-9-methyl-7-(4,7-diazaspiro[2.5]octan-7-yl)-4H-pyrido[1,2-a]pyrimidin-4-one [ No CAS ]

Reference： [1]Patent: WO2015/173181,2015,A1
[2]Patent: WO2017/81111,2017,A1
[3]Patent: WO2017/80967,2017,A1

14
[ 886365-56-6 ]
9-methyl-2-(2-methylimidazo[1,2-b]pyridazin-6-yl)-7-[(3S)-3-methylpiperazin-1-yl]pyrido[1,2-a]pyrimidin-4-one [ No CAS ]

Reference： [1]Patent: WO2015/173181,2015,A1
[2]Patent: WO2017/81111,2017,A1
[3]Patent: WO2017/80967,2017,A1
[4]Patent: US2019/315773,2019,A1

15
[ 886365-56-6 ]
9-methyl-2-(2-methylimidazo[1,2-b]pyridazin-6-yl)-7-[(3R)-3-methylpiperazin-1-yl]pyrido[1,2-a]pyrimidin-4-one [ No CAS ]

Reference： [1]Patent: WO2015/173181,2015,A1
[2]Patent: WO2017/81111,2017,A1
[3]Patent: WO2017/80967,2017,A1
[4]Patent: US2019/315773,2019,A1

16
[ 886365-56-6 ]
7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-9-methyl-2-(2-methylimidazo[1,2-b]pyridazin-6-yl)pyrido[1,2-a]pyrimidin-4-one [ No CAS ]

Reference： [1]Patent: WO2015/173181,2015,A1
[2]Patent: WO2017/81111,2017,A1
[3]Patent: WO2017/80967,2017,A1
[4]Patent: US2019/315773,2019,A1

17
[ 886365-56-6 ]
7-(3,3-dimethylpiperazin-1-yl)-9-methyl-2-(2-methylimidazo[1,2-b]pyridazin-6-yl)pyrido[1,2-a]pyrimidin-4-one [ No CAS ]

Reference： [1]Patent: WO2015/173181,2015,A1
[2]Patent: WO2017/81111,2017,A1
[3]Patent: WO2017/80967,2017,A1
[4]Patent: US2019/315773,2019,A1

18
[ 886365-56-6 ]
7-(4,7-diazaspiro[2.5]octan-7-yl)-9-methyl-2-(2-methylimidazo[1,2-b]pyridazin-6-yl)pyrido[1,2-a]pyrimidin-4-one [ No CAS ]

Reference： [1]Patent: WO2015/173181,2015,A1
[2]Patent: WO2017/81111,2017,A1
[3]Patent: WO2017/80967,2017,A1
[4]Patent: US2019/315773,2019,A1

19
[ 886365-56-6 ]
7-[(3S,5S)-3,5-dimethylpiperazin-1-yl]-9-methyl-2-(2-methylimidazo[1,2-b]pyridazin-6-yl)pyrido[1,2-a]pyrimidin-4-one [ No CAS ]

Reference： [1]Patent: WO2015/173181,2015,A1
[2]Patent: WO2017/81111,2017,A1
[3]Patent: WO2017/80967,2017,A1
[4]Patent: US2019/315773,2019,A1

20
[ 886365-56-6 ]
[ 108-59-8 ]
7-fluoro-2-hydroxy-9-methyl-pyrido [1,2-a]pyrimidin-4-one [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	at 210℃; for 15h;	a) 2-chloro-7-fluoro-9-methyl-pyridor 1 ,2-alpyrimidin-4-one A mixture of <strong>[886365-56-6]5-fluoro-3-methylpyridin-2-amine</strong> (3.3 g, 26.2 mmol) and dimethyl malonate (15.0 mL, 0.13 mol, 5.0 eq.) was heated at 210 C for 1.5 hours. After cooling to room temperature, the precipitate was filtered and washed with ACN (3x) to give 7-fluoro-2-hydroxy- 9-methyl-pyrido[l,2-a]pyrimidin-4-one as a dark solid (2.3 g), which was used directly in the next step. MS m/z 195.1 [M+H]+. A mixture of crude 7-fluoro-2-hydroxy-9-methyl-pyrido[l,2-a]pyrimidin-4-one (2.3 g, 11.8 mmol) in POCl3 (7.7 mL, 82.9 mmol) and DIEA (2.07 mL, 11.8 mmol) was heated at 110 C for 15 hours. The solvent was removed and the residue was treated with ice-water, washed with water (3x) and dried to give a brown solid. The crude brown solid was chromatographed (5% MeOH in CH2C12) to give 2-chloro-7-fluoro-9-methyl-pyrido[l,2- a]pyrimidin-4-one as a yellow solid (1.77 g, 70% over 2 steps), MS m/z 213.1 [M+H]+.
	at 210℃; for 1.5h;	A mixture of <strong>[886365-56-6]5-fluoro-3-methylpyridin-2-amine</strong> (3.3 g, 26.2 mmol) and dimethyl malonate(15.0 mL, 0.13 mol, 5.0 eq.) was heated at 210 C for 1.5 h. After cooling to room temperature,the precipitate was filtered and washed with ACN (3x) to give 7-fluoro-2-hydroxy-9-methyl- pyrido[1,2-a]pyrimidin-4-one as a dark solid (2.3 g), which was used directly in the next step. MS mlz 195.1 [M+H].
	at 210℃; for 1.5h;	A mixture of <strong>[886365-56-6]5-fluoro-3-methylpyridin-2-amine</strong> (3.3 g, 26.2 mmol) and dimethyl malonate (15.0 mL, 0.13 mol, 5.0 eq.) was heated at 210 C for 1.5 hours. After cooling to room temperature, the precipitate was filtered and washed with ACN (3x) to give 7-fluoro-2-hydroxy- 9-methyl-pyrido[1,2-a]pyrimidin-4-one as a dark solid (2.3 g), which was used directly in thenext step. MS m/z 195.1 [M+Hf?.

2.3 g	at 210℃; for 1.5h;	A mixture of <strong>[886365-56-6]5-fluoro-3-methylpyridin-2-amine</strong> (3.3 g, 26.2 mmol) and dimethyl malonate (15.0 mL, 0.13 mol, 5.0 eq.) was heated at 210 C for 1.5 hours. After cooling to room temperature, the precipitate was filtered and washed with ACN (3x) to give 7-fluoro-2-hydroxy- 9-methyl-pyrido[1,2-a]pyrimidin-4-one as a dark solid (2.3 g), which was used directly in thenext step. MS m/z 195.1 [M+Hf?.
	at 210℃; for 1.5h;	A mixture of <strong>[886365-56-6]5-fluoro-3-methylpyridin-2-amine</strong> (3.3 g, 26.2 mmol) and dimethyl malonate (15.0 mL, 0.13 mol, 5.0 eq.) was heated at 210 C. for 1.5 hours. After cooling to room temperature, the precipitate was filtered and washed with ACN (3*) to give 7-fluoro-2-hydroxy-9-methyl-pyrido[1,2-a]pyrimidin-4-one as a dark solid (2.3 g), which was used directly in the next step. MS m/z 195.1 [M+H]+.

Reference： [1]Patent: WO2015/173181,2015,A1 .Location in patent: Page/Page column 34-35
[2]Patent: WO2016/184832,2016,A1 .Location in patent: Page/Page column 40
[3]Patent: WO2017/81111,2017,A1 .Location in patent: Page/Page column 34
[4]Patent: WO2017/80967,2017,A1 .Location in patent: Page/Page column 56
[5]Patent: US2019/315773,2019,A1 .Location in patent: Paragraph 0268-0269

21
[ 886365-56-6 ]
7-(2,7-diazaspiro[3,5]nonan-2-yl)-9-methyl-2-(2-methyl-[1,2,4]triazolo[1,5-b]pyridazin-6-yl)pyrido[1,2-a]pyrimidin-4-one 2,2,2-trifluoroacetic acid [ No CAS ]

Reference： [1]Patent: WO2016/184832,2016,A1

22
[ 886365-56-6 ]
7-(2,7-diazaspiro[3,4]octan-2-yl)-9-methyl-2-(2-methyl-[1,2,4]triazolo[1,5-b]pyridazin-6-yl)pyrido [1,2-a]pyrimidin-4-one 2,2,2-trifluoroacetic acid [ No CAS ]

Reference： [1]Patent: WO2016/184832,2016,A1

23
[ 886365-56-6 ]
7-fluoro-9-methyl-2-(2-methyl-[1,2,4]triazolo[1,5-b]pyridazin-6-yl)pyrido[1,2-a]pyrimidin-4-one [ No CAS ]

Reference： [1]Patent: WO2016/184832,2016,A1

24
[ 886365-56-6 ]
9-methyl-7-piperazin-1-yl-2-(2-methyl-[1,2,4]triazolo[1,5-b]pyridazin-6-yl)pyrido[1,2-a]pyrimidin-4-one [ No CAS ]

Reference： [1]Patent: WO2016/184832,2016,A1

25
[ 886365-56-6 ]
9-methyl-7-(4-methyl-1,4-diazepan-1-yl)-2-(2-methyl-[1,2,4]triazolo[1,5-b]pyridazin-6-yl)pyrido[1,2-a]pyrimidin-4-one [ No CAS ]

Reference： [1]Patent: WO2016/184832,2016,A1

26
[ 886365-56-6 ]
7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-9-methyl-2-(2-methyl-[1,2,4]triazolo[1,5-b]pyridazin-6-yl)pyrido[1,2-a]pyrimidin-4-one [ No CAS ]

Reference： [1]Patent: WO2016/184832,2016,A1

Related Products

Historical Records

Related Functional Groups of
[ 886365-56-6 ]

Fluorinated Building Blocks

[ 301222-66-2 ]

2-Amino-5-fluoro-4-picoline

Similarity: 0.82

[ 868636-72-0 ]

5-Fluoro-N-methylpyridin-2-amine

Similarity: 0.78

[ 1211537-08-4 ]

4,5-Difluoropyridin-2-amine

Similarity: 0.78

[ 1401426-18-3 ]

5-Fluoro-2-hydrazinylpyridine dihydrochloride

Similarity: 0.77

[ 1956436-47-7 ]

(S)-1-(5-Fluoropyridin-3-yl)ethanamine hydrochloride

Similarity: 0.77

Amines

[ 301222-66-2 ]

2-Amino-5-fluoro-4-picoline

Similarity: 0.82

[ 868636-72-0 ]

5-Fluoro-N-methylpyridin-2-amine

Similarity: 0.78

[ 1211537-08-4 ]

4,5-Difluoropyridin-2-amine

Similarity: 0.78

[ 1401426-18-3 ]

5-Fluoro-2-hydrazinylpyridine dihydrochloride

Similarity: 0.77

[ 1956436-47-7 ]

(S)-1-(5-Fluoropyridin-3-yl)ethanamine hydrochloride

Similarity: 0.77

Related Parent Nucleus of
[ 886365-56-6 ]

Pyridines

[ 301222-66-2 ]

2-Amino-5-fluoro-4-picoline

Similarity: 0.82

[ 868636-72-0 ]

5-Fluoro-N-methylpyridin-2-amine

Similarity: 0.78

[ 1211537-08-4 ]

4,5-Difluoropyridin-2-amine

Similarity: 0.78

[ 1401426-18-3 ]

5-Fluoro-2-hydrazinylpyridine dihydrochloride

Similarity: 0.77

[ 1956436-47-7 ]

(S)-1-(5-Fluoropyridin-3-yl)ethanamine hydrochloride

Similarity: 0.77

Ghs Precautionary Statements

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Purity	Size	Price	VIP Price	USA Stock *0-1 Day	Global Stock *5-7 Days	Quantity
{[ item.p_purity ]}	{[ item.pr_size ]}	{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]}	{[ getRatePrice(item.pr_usd, 1,1) ]}	{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]}	{[ item.pr_usastock ]}	Inquiry -	{[ item.pr_chinastock ]}	Inquiry -

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed
H304	May be fatal if swallowed and enters airways
H305	May be harmful if swallowed and enters airways
H310	Fatal in contact with skin
H311	Toxic in contact with skin
H312	Harmful in contact with skin
H313	May be harmful in contact with skin
H314	Causes severe skin burns and eye damage
H315	Causes skin irritation
H316	Causes mild skin irritation
H317	May cause an allergic skin reaction
H318	Causes serious eye damage
H319	Causes serious eye irritation
H320	Causes eye irritation
H330	Fatal if inhaled
H331	Toxic if inhaled
H332	Harmful if inhaled
H333	May be harmful if inhaled
H334	May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335	May cause respiratory irritation
H336	May cause drowsiness or dizziness
H340	May cause genetic defects
H341	Suspected of causing genetic defects
H350	May cause cancer
H351	Suspected of causing cancer
H360	May damage fertility or the unborn child
H361	Suspected of damaging fertility or the unborn child
H361d	Suspected of damaging the unborn child
H362	May cause harm to breast-fed children
H370	Causes damage to organs
H371	May cause damage to organs
H372	Causes damage to organs through prolonged or repeated exposure
H373	May cause damage to organs through prolonged or repeated exposure
Environmental hazards
Code	Phrase
H400	Very toxic to aquatic life
H401	Toxic to aquatic life
H402	Harmful to aquatic life
H410	Very toxic to aquatic life with long-lasting effects
H411	Toxic to aquatic life with long-lasting effects
H412	Harmful to aquatic life with long-lasting effects
H413	May cause long-lasting harmful effects to aquatic life
H420	Harms public health and the environment by destroying ozone in the upper atmosphere

[ CAS No. 886365-56-6 ]

Quality Control of [ 886365-56-6 ]

Related Doc. of [ 886365-56-6 ]

Product Details of [ 886365-56-6 ]

Safety of [ 886365-56-6 ]

Application In Synthesis of [ 886365-56-6 ]

[ 886365-56-6 ] Synthesis Path-Upstream 1~1

[ 886365-56-6 ] Synthesis Path-Downstream 1~26

Related Functional Groups of [ 886365-56-6 ]

Fluorinated Building Blocks

Amines

Related Parent Nucleus of [ 886365-56-6 ]

Pyridines

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Related Functional Groups of
[ 886365-56-6 ]

Related Parent Nucleus of
[ 886365-56-6 ]